polyvalent group B streptococcal vaccine (Baxter)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepolyvalent group B streptococcal vaccine (Baxter)
Drug Alias NameGroup B streptococcal vaccine (North American Vaccine)polyvalent group B streptococcal vaccine (North American Vaccine)tetravalent GBS conjugate vaccine (North American Vaccine)polyvalent GBS vaccine (Baxter)tetravalent GBS vaccine (Baxter)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsStreptococcus group B infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorth American Vaccine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorth American Vaccine IncBaxter International Inc
Active IndicationsN/A
Inactive IndicationsStreptococcus group B infection

Other Information

ATC CodeN/A
Related LinksN/A